The excessive and inappropriate use of antibiotics is a paramount global health threat, directly fueling the escalating crisis of antimicrobial resistance (
19,
24). Our study sheds light on a critical facet of this problem within our local context, revealing an alarming rate (98.5%) of prophylactic antibiotic prescription for simple traumatic wounds in the EDs of two major hospitals in southwestern Iran. This finding indicates that prescribing is overwhelmingly routine and non-selective, representing a significant deviation from contemporary evidence-based guidelines that explicitly advise against this practice for uncomplicated wounds in immunocompetent patients (
12,
25).
The near-universal prescription rate we observed not only confirms but exceeds the high rates reported in other Iranian studies. For instance, Basir Ghafouri et al. reported a 90.5% prescription rate, noting that only 19.6% of those prescriptions had a valid clinical indication (
18). The disparity between our finding and theirs underscores that this is a pervasive and potentially worsening issue in the region. This profound gap between established evidence and clinical practice points to an urgent need for multifaceted interventions, including targeted educational programs for physicians and the robust implementation of antimicrobial stewardship programs (ASPs) specifically tailored to the fast-paced ED environment (
26,
27).
The choice of cephalexin as the predominant antibiotic (92.2% overall) is pharmacologically sound when prophylaxis is truly indicated. First-generation cephalosporins like cephalexin provide excellent coverage against common skin pathogens such as
Staphylococcus and
Streptococcus species (
28,
29). This suggests that when physicians decide to prescribe, their drug selection is appropriate. The critical issue, therefore, is not the choice of agent but the fundamental lack of a clear indication for any prophylactic antibiotic in the vast majority of these simple wound cases.
Our detailed subgroup analyses revealed that cephalexin prescribing peaked in the 21 - 30-year age group, males, lacerations, extremity wounds, and clean wounds, reflecting trauma epidemiology rather than risk-based decision-making. Significant associations persisted across gender, location, and contamination for both primary and secondary agents, yet the near-100% prescription rate in low-risk subgroups underscores habitual rather than selective use. Combination therapy (13%), though less common, followed similar patterns, with cefazolin predominant as the second agent.
The underlying reasons for this pervasive over-prescription are likely multifactorial. They may include a lack of awareness of current guidelines, perceived pressure from patients for a prescription, defensive medicine practices due to medico-legal concerns, and time constraints in the busy EDs setting that favor prescribing over patient education on proper wound care. Addressing this will require a cultural shift alongside structural and educational interventions.
5.1. Limitations
The interpretations of this study must be considered in the context of its limitations. First, the retrospective design inherently relies on the accuracy, consistency, and completeness of documentation in medical records, which may introduce information bias. Second, we could not assess the quality of crucial wound management steps, such as the adequacy of irrigation or debridement, which are critical confounding factors known to be the cornerstone of infection prevention. The absence of this data limits our ability to fully contextualize the prescribing decisions. Third, and perhaps most significantly, the lack of follow-up data means we cannot determine the actual incidence of wound infections in this cohort. Consequently, we are unable to evaluate the clinical outcome or the purported "benefit" of this widespread prescribing practice, nor can we identify the true infection risk in our population, which is essential for crafting relevant local guidelines.
5.2. Conclusions
This study identified a near-universal and likely inappropriate rate of prophylactic antibiotic prescription for simple traumatic wounds in the studied EDs, a practice that stands in stark contrast to international evidence-based guidelines. This represents a significant opportunity for quality improvement and a compelling call to action for enhanced antimicrobial stewardship. To bridge this gap between evidence and practice, we recommend a concerted effort to:
-Develop and implement clear, easy-to-follow local prescribing guidelines for traumatic wound management.
-Initiate targeted educational interventions for ED physicians, focusing on the evidence against routine prophylaxis and emphasizing the primacy of meticulous wound care.
-Conduct prospective studies that include patient follow-up to definitively assess the clinical necessity and impact of this prescribing practice, and to identify the true risk factors for infection in our patient population.
Such steps are urgently needed to promote the rational use of antibiotics, curb the development of resistance, and ensure patient safety in our emergency care setting.